![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1350247 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LPAR4 mRNA | CTD | PMID:22079256 | (2,4,5-trichlorophenoxy)acetic acid | decreases expression | ISO | RGD:1557960 | 6480464 | 2 more ... | CTD | PMID:18579281 | (S)-nicotine | multiple interactions | ISO | RGD:1557960 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | decreases expression | ISO | RGD:1557960 | 6480464 | 2 more ... | CTD | PMID:25575267 | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | RGD:1557960 | 6480464 | 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:1557960 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | 17beta-estradiol | decreases expression | ISO | RGD:1557960 | 6480464 | Estradiol results in decreased expression of LPAR4 mRNA | CTD | PMID:25575267 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | RGD:1350247 | 6480464 | 2 more ... | CTD | PMID:31173147 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1557960 | 6480464 | Tetrachlorodibenzodioxin affects the expression of LPAR4 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LPAR4 mRNA | CTD | PMID:32109520 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | RGD:1557960 | 6480464 | tetrabromobisphenol A results in decreased expression of LPAR4 mRNA | CTD | PMID:25172293 | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of LPAR4 mRNA | CTD | PMID:30071829 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of LPAR4 mRNA | CTD | PMID:24780913 | aflatoxin B1 | decreases methylation | ISO | RGD:1350247 | 6480464 | Aflatoxin B1 results in decreased methylation of LPAR4 gene | CTD | PMID:27153756 | aldrin | decreases expression | ISO | RGD:1557960 | 6480464 | Aldrin results in decreased expression of LPAR4 mRNA | CTD | PMID:18579281 | all-trans-retinoic acid | decreases expression | ISO | RGD:1350247 | 6480464 | Tretinoin results in decreased expression of LPAR4 mRNA | CTD | PMID:21934132, PMID:33167477 | arsenous acid | multiple interactions | ISO | RGD:1350247 | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LPAR4 protein] | CTD | PMID:26598702 | benzo[a]pyrene | decreases methylation | ISO | RGD:1350247 | 6480464 | Benzo(a)pyrene results in decreased methylation of LPAR4 3' UTR, Benzo(a)pyrene results in decreased methylation of LPAR4 exon | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | RGD:1350247 | 6480464 | Benzo(a)pyrene affects the methylation of LPAR4 promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1350247 | 6480464 | Diethylhexyl Phthalate results in decreased expression of LPAR4 mRNA | CTD | PMID:31163220 | bisphenol A | decreases expression | ISO | RGD:1557960 | 6480464 | bisphenol A results in decreased expression of LPAR4 mRNA | CTD | PMID:25575267 | bisphenol A | decreases methylation | ISO | RGD:1350247 | 6480464 | bisphenol A results in decreased methylation of LPAR4 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of LPAR4 mRNA | CTD | PMID:33296240 | bisphenol A | increases expression | ISO | RGD:1557960 | 6480464 | bisphenol A results in increased expression of LPAR4 mRNA | CTD | PMID:30951980 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LPAR4 mRNA | CTD | PMID:25181051, PMID:34947998 | bisphenol F | increases expression | ISO | RGD:1557960 | 6480464 | bisphenol F results in increased expression of LPAR4 mRNA | CTD | PMID:30951980 | caffeine | multiple interactions | ISO | RGD:1557960 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | carbon nanotube | decreases expression | ISO | RGD:1557960 | 6480464 | Nanotubes, Carbon analog results in decreased expression of LPAR4 mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | RGD:1350247 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to LPAR4 gene] | CTD | PMID:28238834 | chloroethene | decreases expression | ISO | RGD:1557960 | 6480464 | Vinyl Chloride results in decreased expression of LPAR4 mRNA | CTD | PMID:18579281 | copper(II) sulfate | decreases expression | ISO | RGD:1557960 | 6480464 | Copper Sulfate results in decreased expression of LPAR4 mRNA | CTD | PMID:18579281 | dextran sulfate | multiple interactions | ISO | RGD:1557960 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LPAR4 mRNA | CTD | PMID:29950665 | diarsenic trioxide | multiple interactions | ISO | RGD:1350247 | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LPAR4 protein] | CTD | PMID:26598702 | diclofenac | decreases expression | ISO | RGD:1557960 | 6480464 | Diclofenac results in decreased expression of LPAR4 mRNA | CTD | PMID:26934552 | diethylstilbestrol | decreases expression | ISO | RGD:1557960 | 6480464 | Diethylstilbestrol results in decreased expression of LPAR4 mRNA | CTD | PMID:25575267 | diquat | decreases expression | ISO | RGD:1557960 | 6480464 | Diquat results in decreased expression of LPAR4 mRNA | CTD | PMID:36851058 | dorsomorphin | multiple interactions | ISO | RGD:1350247 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of LPAR4 mRNA | CTD | PMID:29391264 | estriol | decreases expression | ISO | RGD:1557960 | 6480464 | Estriol results in decreased expression of LPAR4 mRNA | CTD | PMID:25575267 | inulin | multiple interactions | ISO | RGD:1557960 | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of LPAR4 mRNA | CTD | PMID:36331819 | methylmercury chloride | decreases expression | ISO | RGD:1350247 | 6480464 | methylmercuric chloride results in decreased expression of LPAR4 mRNA | CTD | PMID:28001369 | miconazole | decreases expression | ISO | RGD:1557960 | 6480464 | Miconazole results in decreased expression of LPAR4 mRNA | CTD | PMID:27462272 | nickel atom | decreases expression | ISO | RGD:1350247 | 6480464 | Nickel results in decreased expression of LPAR4 mRNA | CTD | PMID:25583101 | nicotine | multiple interactions | ISO | RGD:1557960 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of LPAR4 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1557960 | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of LPAR4 mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | RGD:1350247 | 6480464 | Phenylmercuric Acetate results in decreased expression of LPAR4 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1350247 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR4 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | ISO | RGD:1350247 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LPAR4 mRNA | CTD | PMID:19710929 | potassium chromate | multiple interactions | ISO | RGD:1350247 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LPAR4 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | RGD:1350247 | 6480464 | potassium chromate(VI) results in decreased expression of LPAR4 mRNA | CTD | PMID:22079256 | SB 431542 | multiple interactions | ISO | RGD:1350247 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silver atom | decreases expression | ISO | RGD:1557960 | 6480464 | Silver results in decreased expression of LPAR4 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | RGD:1557960 | 6480464 | Silver results in decreased expression of LPAR4 mRNA | CTD | PMID:27131904 | titanium dioxide | multiple interactions | ISO | RGD:1557960 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LPAR4 mRNA | CTD | PMID:29950665 | trichostatin A | decreases expression | ISO | RGD:1350247 | 6480464 | trichostatin A results in decreased expression of LPAR4 mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | ISO | RGD:1350247 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR4 mRNA | CTD | PMID:27188386 | triticonazole | increases expression | EXP | | 6480464 | triticonazole results in increased expression of LPAR4 mRNA | CTD | PMID:36084822 | valproic acid | decreases methylation | ISO | RGD:1350247 | 6480464 | Valproic Acid results in decreased methylation of LPAR4 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | RGD:1350247 | 6480464 | Valproic Acid affects the expression of LPAR4 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | RGD:1557960 | 6480464 | Valproic Acid results in increased expression of LPAR4 mRNA | CTD | PMID:24896083 | valproic acid | decreases expression | ISO | RGD:1350247 | 6480464 | Valproic Acid results in decreased expression of LPAR4 mRNA | CTD | PMID:24383497 more ... | valproic acid | multiple interactions | ISO | RGD:1350247 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR4 mRNA | CTD | PMID:27188386 | |